John M. McCarty

7.1k total citations · 3 hit papers
70 papers, 3.6k citations indexed

About

John M. McCarty is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, John M. McCarty has authored 70 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 18 papers in Immunology and 14 papers in Oncology. Recurrent topics in John M. McCarty's work include Hematopoietic Stem Cell Transplantation (36 papers), Acute Myeloid Leukemia Research (15 papers) and Acute Lymphoblastic Leukemia research (11 papers). John M. McCarty is often cited by papers focused on Hematopoietic Stem Cell Transplantation (36 papers), Acute Myeloid Leukemia Research (15 papers) and Acute Lymphoblastic Leukemia research (11 papers). John M. McCarty collaborates with scholars based in United States, Canada and Switzerland. John M. McCarty's co-authors include John F. DiPersio, Patrick J. Stiff, Gary Bridger, Richard T. Maziarz, Ivana N. Micallef, Christopher D. Benjamin, John M. Harlan, Kelly L. Hudkins, Gary Calandra and Daniel Fishbein and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

John M. McCarty

69 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

2004 606 citations Patrick J. Stiff, Thomas C. Shea et al. profile →
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

1993 602 citations Kevin D. O’Brien, Margaret D. Allen et al. Journal of Clinical Investigation profile →
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. McCarty United States	23	1.8k	983	856	623	590	70	3.6k
Yasushi Takamatsu Japan	27	1.6k 0.9×	1.3k 1.4×	1.1k 1.3×	282 0.5×	695 1.2×	159	3.6k
Aaron P. Rapoport United States	32	1.1k 0.6×	2.1k 2.1×	703 0.8×	350 0.6×	1.2k 2.0×	162	3.8k
P. J. Tutschka United States	32	2.0k 1.1×	738 0.8×	1.2k 1.4×	458 0.7×	463 0.8×	95	3.8k
Suresh H. Advani India	25	708 0.4×	1.1k 1.1×	415 0.5×	460 0.7×	578 1.0×	250	3.0k
Farshid Dayyani United States	32	344 0.2×	1.5k 1.5×	975 1.1×	768 1.2×	1.1k 1.9×	149	4.2k
John Gibson Australia	34	2.1k 1.1×	1.3k 1.4×	1.5k 1.7×	129 0.2×	966 1.6×	161	3.6k
Dennis Cooper United States	27	951 0.5×	1.1k 1.1×	466 0.5×	367 0.6×	461 0.8×	112	2.8k
Gordon L. Phillips United States	26	1.6k 0.9×	1.0k 1.0×	643 0.8×	490 0.8×	476 0.8×	87	3.8k
Michael G. Alexandrakis Greece	29	755 0.4×	767 0.8×	429 0.5×	498 0.8×	573 1.0×	104	2.3k
Hyeoung‐Joon Kim South Korea	29	1.4k 0.8×	909 0.9×	957 1.1×	139 0.2×	1.0k 1.7×	213	3.0k

Countries citing papers authored by John M. McCarty

Since Specialization

Citations

This map shows the geographic impact of John M. McCarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. McCarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. McCarty more than expected).

Fields of papers citing papers by John M. McCarty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. McCarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. McCarty. The network helps show where John M. McCarty may publish in the future.

Co-authorship network of co-authors of John M. McCarty

This figure shows the co-authorship network connecting the top 25 collaborators of John M. McCarty. A scholar is included among the top collaborators of John M. McCarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. McCarty. John M. McCarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eapen, Mary, Joseph H. Antin, Jakub Tolar, et al.. (2024). Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study. EClinicalMedicine. 76. 102819–102819. 3 indexed citations

McCarty, John M., et al.. (2019). Bronchoalveolar lavage to evaluate new pulmonary infiltrates in allogeneic hematopoietic stem cell transplant recipients: impact on antimicrobial optimization. Infection Prevention in Practice. 1(3-4). 100029–100029. 5 indexed citations

Micallef, Ivana N., Patrick J. Stiff, Auayporn Nademanee, et al.. (2018). Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biology of Blood and Marrow Transplantation. 24(6). 1187–1195. 36 indexed citations

Toor, Amir A., Roy Sabo, Catherine Roberts, et al.. (2015). Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes. Biology of Blood and Marrow Transplantation. 21(7). 1237–1245. 14 indexed citations

Curtis, Lisa M., Manuel B. Datiles, Seth M. Steinberg, et al.. (2015). Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. Haematologica. 100(9). 1228–1236. 15 indexed citations

Wetzler, Meir, D. Watson, Wendy Stock, et al.. (2013). Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance). Haematologica. 99(1). 111–115. 68 indexed citations

Levy, Emily R., John M. McCarty, Andi L. Shane, & Peggy Sue Weintrub. (2013). Treatment of Pediatric Refractory Coccidioidomycosis With Combination Voriconazole and Caspofungin: A Retrospective Case Series. Clinical Infectious Diseases. 56(11). 1573–1578. 30 indexed citations

Kmieciak, Maciej, Roy Sabo, Catherine Roberts, et al.. (2012). Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation. Transplantation. 93(9). 949–957. 17 indexed citations

Shaughnessy, Paul, Joseph P. Uberti, Steven M. Devine, et al.. (2012). Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access program. Bone Marrow Transplantation. 48(6). 777–781. 29 indexed citations

10.

Tolar, Jakub, H. Joachim Deeg, Sally Arai, et al.. (2012). Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels. Biology of Blood and Marrow Transplantation. 18(7). 1007–1011. 35 indexed citations

11.

Toor, Amir A., Roy Sabo, Catherine Roberts, et al.. (2011). Favorable Outcomes in Patients with High Donor-Derived T Cell Count after In Vivo T Cell–Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(5). 794–804. 9 indexed citations

12.

Shea, Thomas C., Jeffrey L. Johnson, Peter Westervelt, et al.. (2011). Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901. Biology of Blood and Marrow Transplantation. 17(9). 1395–1403. 46 indexed citations

13.

Fletcher, David, Roy Sabo, William Clark, et al.. (2011). Use of Rabbit Anti-Thymocyte Globulin for Conditioning in Matched Unrelated Donor Hematopoietic Cell Transplantation Provides Comparable Dose Dependant Outcomes to Matched Related Donor Recipients. Biology of Blood and Marrow Transplantation. 17(2). S303–S303. 1 indexed citations

14.

DiPersio, John F., Ivana N. Micallef, Patrick J. Stiff, et al.. (2009). Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology. 27(28). 4767–4773. 512 indexed citations breakdown →

15.

Calandra, Gary, John M. McCarty, Joseph P. McGuirk, et al.. (2007). AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplantation. 41(4). 331–338. 221 indexed citations

16.

Sydnor, M.K., et al.. (2003). Mycotic osteomyelitis due to Scedosporium Apiospermum: MR imaging-pathologic correlation. Skeletal Radiology. 32(11). 656–660. 11 indexed citations

17.

Kaushik, Shaifali, et al.. (2002). Granulomatous myositis: a manifestation of chronic graft-versus-host disease. Skeletal Radiology. 31(4). 226–229. 11 indexed citations

18.

Kaushansky, Kenneth, et al.. (1994). Coordinate regulation of multiple human lymphokine genes by Oct-1 and potentially novel 45 and 43 kDa polypeptides.. The Journal of Immunology. 152(4). 1812–1820. 38 indexed citations

19.

McCarty, John M.. (1994). Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. European Journal of Clinical Microbiology & Infectious Diseases. 13(10). 846–850. 26 indexed citations

20.

O’Brien, Kevin D., Margaret D. Allen, Thomas O. McDonald, et al.. (1993). Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.. Journal of Clinical Investigation. 92(2). 945–951. 602 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact